The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

Toxoplasma gondii is a widespread parasite responsible for toxoplasmosis, an infection that often lacks clear symptoms but ...

Reports DescriptionAccording to the analysis conducted by Custom Market Insights (CMI), the Ultomiris drug market is ...

The FDA has approved Gammagard Liquid ERC as a replacement therapy for PI in adult and pediatric patients 2 years of age and older.

Biogen has announced that it has initiated a phase 3 study of investigational felzartamab in adults with primary membranous ...

BIIB begins phase III dosing of felzartamab primary membranous nephropathy study, targeting a tough-to-treat condition with ...

The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous ...

SAN FRANCISCO and VANCOUVER, British Columbia, July 01, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: ...

The FDA has approved Takeda’s new immunoglobulin therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat ...

This new article explores some of the possible reasons behind gluten sensitivity, such as various allergens and infections.